Abstract：Objective To develop an early diagnosis strategy for radiation-associated breast angiosarcoma after breast cancer radiotherapy (RABASBCR) and to avoid the misdiagnosis of this disease. Methds A systematic search of PubMed for published reports of RABASBCR cases was performed. The clinical manifestations and radiological features in the early stage of disease, as well as biopsies, were analyzed to screen out valuable markers for early diagnosis and develop the early diagnosis strategy for RABASBCR. Results Fifty-five original articles involving 80 RABASBCR patients were selected for this analysis. Twenty-four (30%) of the 80 patients were misdiagnosed;the median time of misdiagnosis was 3 months (1-24 months). The earliest symptom was skin changes in 76(95%) of the 80 patients. The misdiagnosis rates of ultrasound, mammography, computed tomography, and magnetic resonance imaging for RABASBCR were 9/9, 31/32, 2/2, and 1/5, respectively. The misdiagnosis rates of fine needle biopsy, core needle biopsy, and incisional biopsy were 7/14, 12/25, and 10/26, respectively. Conclusions By analyzing published case reports, we have set up the early diagnosis strategy for RABASBCR with reference to the Cahan criteria.
Shan Bin,Meng Xiangying,Wu Shikai et al. Study on early diagnosis strategy for radiation-associated breast angiosarcoma after breast cancer radiotherapy[J]. Chinese Journal of Radiation Oncology, 2014, 23(6): 475-478.
[1] Abd-Alla HM, Lotayef MM, Abou BA, et al. Ipsilateral in-breast tumor relapse after breast conservation therapy:true recurrence versus new primary tumor[J]. J Egypt Natl Canc Inst,2006,18:183-190. [2] Tahir M, Hendry P, Baird L, et al. Radiation induced angiosarcoma a sequela of radiotherapy for breast cancer following conservative surgery[J/OL]. Int Semin Surg Oncol,2006,3:26[2014-02-01]. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1570350/. [3] Chahin F, Paramesh A, Dwivedi A, et al. Angiosarcoma of the breast following breast preservation therapy and local radiation herapy for breast cancer[J]. Breast J,2001,7:120-123. [4] de Giorgi V, Santi R, Grazzini M, et al. Synchronous angiosarcoma, melanoma and morphea of the breast skin 14 years after radiotherapy for mammary carcinoma[J]. Acta Derm Venereol,2010,90:283-286. [5] Del ML, Garrone O, Guenzi M, et al. Angiosarcoma of the residual breast after conservative surgery and radiotherapy for primary carcinoma. Ann Oncol,1994,5:163-165. [6] Mano MS, Fraser G, Kerr J, et al. Radiation-induced angiosarcoma of the breast shows major response to docetaxel after failure of anthracycline-based chemotherapy[J]. Breast,2006,15:117-118. [7] Cahan WG, Woodard HQ, Higinbotham NL, et al. Sarcoma arising in irradiated bone:report of eleven cases.1948[J].Cancer,1998,82:8-34. [8] Arlen M, Higinbotham NL, Huvos AG,et al. Radiation-induced sarcoma of bone[J]. Cancer,1971,28:1087-1099. [9] Gladdy RA, Qin LX, Moraco N,et al. Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas[J]. J Clin Oncol.2010,28:2064-2069. [10] Sheth GR, Cranmer LD, Smith BD, et al. Radiation-induced sarcoma of the breast:a systematic review[J].Oncologist,2012,17:405-418. [11] 王涛,宋三泰,江泽飞,等.乳腺癌术后放射治疗诱发肉瘤[J].中华放射肿瘤学杂志,2004,13:34-36. [12] 翟梅娟,赵再秋,黄雅萍.乳腺原发性血管肉瘤临床病理分析[J].实用肿瘤学杂志,2006,20:412-413. [13] Fernandez AP, Sun Y, Tubbs RR, et al. FISH for MYC amplification and anti-MYC immunohistochemistry:useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations[J]. J Cutan Pathol,2012,39:234-242.
2014, Vol. 23 
